Oncodesign aacr 2018 morab-202 a folate receptor alpha-targeted antibody-drug conjugate shows a highly potent activity against a panel of FRA-expressing tumors
Oncodesign aacr 2018 presentation by Dr. Mirjolet
Oncodesign aacr 2018 development of a high throughput in vitro screening platform to identify novel inducers of immunological cell death
Oncodesign aacr 2018 humanized mouse models for evaluation of cancer therapies
From syngenic to_humanised_models_mirjolet_oncodesign
Oncodesign : mission, plate-forme technologique, perspectives & objectifs
L’intelligence artificielle et la médecine de précision
Conference on Receptor Tyrosine kinase quantiftation by Ms2plex by X. Morge - Oncotrans 2017
Conference on Receptor Tyrosine kinase quantiftation by Ms2plex by X. Morge - Oncotrans 2017
